Cargando…

ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition

Triglyceride (TG) molecules represent the major storage form of fatty acids, and TG metabolism is essential to human health. However, the mechanistic details surrounding TG metabolism are complex and incompletely elucidated. Although it is known that angiopoietin-like protein 8 (ANGPTL8) increases T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan Q., Pottanat, Thomas G., Zhen, Eugene Y., Siegel, Robert W., Ehsani, Mariam, Qian, Yue-Wei, Konrad, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079461/ https://www.ncbi.nlm.nih.gov/pubmed/33762177 http://dx.doi.org/10.1016/j.jlr.2021.100068

Ejemplares similares

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif
por: Balasubramaniam, Deepa, et al.
Publicado: (2022)

Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity
por: Chen, Yan Q., et al.
Publicado: (2021)

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
por: Chen, Yan Q., et al.
Publicado: (2020)

Decoding the role of angiopoietin-like protein 4/8 complex–mediated plasmin generation in the regulation of LPL activity
por: Chen, Yan Q., et al.
Publicado: (2023)

Angiopoietin-like protein 4/8 complex-mediated plasmin generation leads to cleavage of the complex and restoration of LPL activity
por: Zhen, Eugene Y., et al.
Publicado: (2023)

Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study
por: Ariza, María-José, et al.
Publicado: (2010)

ANGPTL4/8 promotes plasmin-mediated cleavage of LPL inhibitors
por: Kersten, Sander
Publicado: (2023)

GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL Activity
por: Kristensen, Kristian Kølby, et al.
Publicado: (2021)

Serum ANGPTL8 and ANGPTL3 as Predictors of Triglyceride Elevation in Adult Women
por: Stefanska, Anna, et al.
Publicado: (2022)

Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue
por: Ruppert, Philip M.M., et al.
Publicado: (2020)

Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease
por: Biterova, Ekaterina, et al.
Publicado: (2018)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease
por: Helkkula, Pyry, et al.
Publicado: (2021)

Estrogen lowers triglyceride via regulating hepatic APOA5 expression
por: Luo, Fei, et al.
Publicado: (2017)

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
por: Ma, Cheng, et al.
Publicado: (2015)

Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity
por: Yoo, Jeong-Ah, et al.
Publicado: (2015)

SIDT2 Associates with Apolipoprotein A1 (ApoA1) and Facilitates ApoA1 Secretion in Hepatocytes
por: Sampieri, Alicia, et al.
Publicado: (2023)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
por: Whitacre, Brynne E., et al.
Publicado: (2021)

ApoA-1 in Diabetes: Damaged Goods
por: Ory, Daniel S., et al.
Publicado: (2010)

The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
por: Zhang, Ren
Publicado: (2016)

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
por: Lebherz, Corinna, et al.
Publicado: (2007)

MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice
por: Ye, Qiong, et al.
Publicado: (2018)

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
por: Camacho, Jessica, et al.
Publicado: (2019)

RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
por: Watts, Gerald F., et al.
Publicado: (2023)

Bacteria-Derived Recombinant Human ANGPTL8/Betatrophin Significantly Increases the Level of Triglyceride
por: Xu, Fangfang, et al.
Publicado: (2019)

The unsolved mystery of apoA-I recycling in adipocyte
por: Wang, Shuai, et al.
Publicado: (2016)

APOA1-75 G to A Substitution Associated with Severe Forms of CAD, Lower Levels of HDL and apoA-I among Northern Indians
por: Chhabra, S., et al.
Publicado: (2005)

Intracapillary LPL levels in brown adipose tissue, visualized with an antibody-based approach, are regulated by ANGPTL4 at thermoneutral temperatures
por: Song, Wenxin, et al.
Publicado: (2023)

ANGPTL8 deletion attenuates abdominal aortic aneurysm formation in ApoE(−/−) mice
por: Yu, Huahui, et al.
Publicado: (2023)

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
por: Ramms, Bastian, et al.
Publicado: (2019)

LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea
por: Flores, Rhonda, et al.
Publicado: (2019)

A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase
por: Fu, Zhiyao, et al.
Publicado: (2015)

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study
por: Walldius, Göran, et al.
Publicado: (2021)

The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels
por: Zhang, Ren
Publicado: (2021)

Lipid-Associated Variants near ANGPTL3 and LPL Show Parent-of-Origin Specific Effects on Blood Lipid Levels and Obesity
por: Lessmark, Anna, et al.
Publicado: (2021)

Autophagy Alteration in ApoA-I Related Systemic Amyloidosis
por: Del Giudice, Rita, et al.
Publicado: (2022)

APOE, CETP and LPL genes show strong association with lipid levels in Greek children()
por: Smart, M.C., et al.
Publicado: (2010)

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
por: Cedó, Lídia, et al.
Publicado: (2016)

Effects of Individual Amino Acids on PPARα Transactivation, mTORC1 Activation, ApoA-I Transcription and pro-ApoA-I Secretion
por: Tayyeb, Jehad Z., et al.
Publicado: (2022)

Comparison of the structure-function properties of wild-type human apoA-V and a C-terminal truncation associated with elevated plasma triglycerides
por: Stankov, Sylvia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_262ms9i43u6k61ideu129t93hn